Comparison of extracorporeal shock wave therapy with botulinum toxin type A in the treatment of plantar fasciitis

This report has been verified by one or more authors of the original publication.

74 patients with plantar fasciitis were randomized to treatment with either extracorporeal shockwave therapy (ESWT) or botulinum toxin type A (BoNT-A) injections. The purpose of this study was to compare pain on a visual analog scale (VAS), Roles and Maudsley pain scores, plantar fasciitis thickness on ultrasound, and the incidence of adverse events. Patients were followed-up at 1 month. The ESWT group demonstrated a greater reduction in VAS pain at rest and on the Roles and Maudsley score compared to the BoNT-A injections. No significant difference in the incidence of adverse events was observed between groups.